Consumer product safety also suffered. The EPA delayed or abandoned reviews of industrial chemicals under the Toxic Substances Control Act, leaving Americans exposed to substances that career scientists had flagged as health hazards. Former staff note that asbestos regulations—which had been moving toward comprehensive restrictions—were significantly weakened.

The report emphasizes that these aren't abstract policy debates: they translate to measurable health outcomes. Increased chemical exposures correlate with higher rates of childhood asthma, developmental disabilities, cancers, and reproductive harm. Low-income communities and communities of color disproportionately bear these health burdens.

Environmental justice advocates highlight that the rollbacks most severely affect vulnerable populations living near industrial facilities, agricultural areas using intensive pesticides, and communities with aging water infrastructure. These populations already face elevated environmental health risks; weakened EPA protections compound existing inequities.

Former EPA enforcement staff describe a systematic effort to reduce inspections, delay penalties, and settle violations with minimal consequences for polluters. Enforcement actions dropped significantly during the Trump administration, even as self-reported violations by industry increased.

The Biden administration has begun reversing some rollbacks, but former staff emphasize that regulatory processes move slowly. Strengthening chemical restrictions requires years of scientific review, public comment periods, and legal defense against industry challenges. Meanwhile, American families continue exposure to inadequately regulated substances.

Public health researchers note that the full health consequences won't be evident for years or even decades. Chemical exposures during childhood can manifest as increased disease risk in adulthood, creating a lasting public health legacy from the regulatory rollbacks.

The report calls for structural reforms to prevent future political interference with scientific determinations, including stronger protections for career scientists, mandatory public disclosure when political appointees overrule scientific recommendations, and accelerated timelines for reinstating evidence-based protections.

Environmental health advocates emphasize that chemical regulation isn't anti-business—it's pro-health. Many companies have already transitioned to safer alternatives; strong regulations level the playing field and prevent competitive advantage through corner-cutting on safety.

The documentation provides a roadmap for policy correction, but former EPA staff warn that restoring protections requires sustained political will and public pressure. Without systematic reform, future administrations could again prioritize polluter interests over public health.